Monitor for any follow-up filings or news that might explain the timing, but this cluster is small in dollar terms and involves routine executive sales — not an immediate red flag.
Price Chart
Executive Summary
Five C-suite executives at Caribou Biosciences sold shares in a coordinated 7-day window, generating $47,474 in total proceeds from open-market transactions. All sales were conducted at prices between $1.93 and $1.96 per share, indicating routine divestitures rather than event-driven selling.
Key Financial Metrics
Key Facts
- Five C-suite insiders sold a total of 24,317 shares for $47,474 in proceeds over 7 days.
- All transactions were open-market sales (Form 4 'S' codes) with no non-cash or derivative-related activity.
- Sellers include the Chief Technology Officer, Chief Medical Officer, Chief Business Officer, and Chief Legal Officer.
- Total value represents only 0.025% of the company's $186M market cap — well below materiality thresholds.
- Average sale price was ~$1.95/share, consistent with recent trading levels.
Financial Impact
$47,474 in total insider selling over 7 days
Risk Factors
- Perception risk if additional selling follows in coming weeks.
- Concentration of C-suite participation could raise questions about confidence, though dollar amounts are minimal.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CONTEXT: Insider Cluster Data (5 trades, 7d window) | cluster-CRBU-1772226119789 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Jun 11, 2026 16w ago | 8-K | $1.66 $1.94 | ▲ +16.87% | ▲ +14.98% | $1.23 (−25.90%) |
Jun 11, 2026 16w ago | Press Release | $1.66 $1.94 | ▲ +16.87% | ▲ +14.98% | $1.23 (−25.90%) |
Jun 5, 2026 16w ago | DEFA14A | $1.84 $1.83 | ▼ −0.54% | ▼ −2.17% | $1.23 (−33.15%) |
Apr 24, 2026 22w ago | DEFA14A | $2.13 $2.16 | ▲ +1.41% | ▼ −3.55% | $1.23 (−42.25%) |
Mar 5, 2026 30w ago | 8-K | $1.82 $1.95 | ▲ +7.14% | ▲ +9.19% | $1.23 (−32.42%) |
Mar 5, 2026 30w ago | Press Release | $1.82 $1.95 | ▲ +7.14% | ▲ +9.19% | $1.23 (−32.42%) |
Feb 28, 2026 30w ago | Institutional Cluster | $1.84 $1.72 | ▼ −6.52% | ▲ +1.42% | $1.23 (−33.15%) |
Feb 24, 2026 31w ago | Insider Cluster | $2.14 $1.82 | ▼ −14.95% | ▼ −9.97% | $1.23 (−42.52%) |
Feb 24, 2026 31w ago | Insider Cluster | $2.14 $1.82 | ▼ −14.95% | ▼ −9.97% | $1.23 (−42.52%) |
Feb 24, 2026 31w ago | Insider Cluster | $2.14 $1.82 | ▼ −14.95% | ▼ −9.97% | $1.23 (−42.52%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access